Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editor's pick

24-04-2019 | Osteoporosis | Highlight | News

Long-term drug treatment may reduce fracture risk in women with osteoporosis

Findings from a systematic review suggest that long-term drug treatment is associated with a reduction in fracture risk among women with osteoporosis, with different agents having varying long-term safety profiles.

18-04-2019 | Juvenile idiopathic arthritis | View from the clinic | Article

Enabling pediatric patients to make informed treatment choices

Editorial board member Sangeeta Sule reflects on the challenges of enabling pediatric patients to make informed decisions about their own healthcare.

24-04-2019 | Quality of life | Podcast | Article

Talking to patients about mental health

Dana DiRenzo discusses the impact of rheumatic diseases on mental health, and treatments and tools that are available to help support patients with these conditions.

Latest from across the site

25-04-2019 | Osteoporosis | News

No difference in fracture risk with denosumab vs alendronate

Patients initiating denosumab have a similar 3-year fracture risk to those initiating alendronate, regardless of sex, age, or fracture history, show results of a large study among Danish patients in routine clinical practice.

24-04-2019 | Rheumatoid arthritis | News

HDL cholesterol levels may predict CV risk in tofacitinib-treated RA patients

Increasing levels of high-density lipoprotein cholesterol are associated with a reduction in cardiovascular risk among rheumatoid arthritis patients undergoing treatment with the Janus kinase inhibitor tofacitinib, researchers report.

24-04-2019 | Quality of life | Podcast | Article

Talking to patients about mental health

Dana DiRenzo discusses the impact of rheumatic diseases on mental health, and treatments and tools that are available to help support patients with these conditions.

24-04-2019 | Osteoporosis | Highlight | News

Long-term drug treatment may reduce fracture risk in women with osteoporosis

Findings from a systematic review suggest that long-term drug treatment is associated with a reduction in fracture risk among women with osteoporosis, with different agents having varying long-term safety profiles.

23-04-2019 | Rheumatoid arthritis | News

Reducing tocilizumab frequency may jeopardize remission status in RA

Doubling the dose interval of subcutaneous tocilizumab after 24 weeks reduces the likelihood of maintaining remission without improving tolerability in patients with moderate-to severe rheumatoid arthritis, study findings indicate.

18-04-2019 | Rheumatoid arthritis | News

Statins may have some benefits in patients with RA

Findings from the TRACE RA trial suggest that atorvastatin has a favorable safety profile and may reduce low-density lipoprotein cholesterol levels in patients with rheumatoid arthritis.

Latest from us on Twitter

Trending this week

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits